T. Inami

Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)

K. Tatsumi, I. Tsujino, H. Kumamaru, 2024, Pharmaceuticals.